Perspective Therapeutics (CATX) Cash from Investing Activities (2016 - 2025)
Perspective Therapeutics (CATX) has disclosed Cash from Investing Activities for 16 consecutive years, with $28.5 million as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities rose 120.59% to $28.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.2 million through Dec 2025, up 118.83% year-over-year, with the annual reading at $41.2 million for FY2025, 118.83% up from the prior year.
- Cash from Investing Activities hit $28.5 million in Q4 2025 for Perspective Therapeutics, up from $14.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $35.2 million in Q4 2021 to a low of -$138.6 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$9.6 million across 5 years, with a median of -$149000.0 in 2022.
- Biggest five-year swings in Cash from Investing Activities: surged 97261.54% in 2023 and later tumbled 155632.58% in 2024.
- Year by year, Cash from Investing Activities stood at $35.2 million in 2021, then tumbled by 181.98% to -$28.8 million in 2022, then skyrocketed by 99.69% to -$89000.0 in 2023, then crashed by 155632.58% to -$138.6 million in 2024, then surged by 120.59% to $28.5 million in 2025.
- Business Quant data shows Cash from Investing Activities for CATX at $28.5 million in Q4 2025, $14.0 million in Q3 2025, and $4.3 million in Q2 2025.